Nvidia CEO Jensen Huang has publicly committed to a landmark investment in OpenAI, calling it potentially the company's largest ever, while forcefully refuting reports of hesitation. The move deepens the strategic ties between the AI chip giant and the leading AI research lab.
Hong Kong-listed construction firm Affluent Foundation Holdings (SEHK:1757) has unveiled plans to enter the regulated financial services sector, sending its shares on a meteoric rise. As the stock trades at a significant premium, analysts question whether the market is pricing in future success or overlooking execution risks.
As major indices climb, a segment of investors is turning their gaze to high-risk, high-reward penny stocks. We examine three companies—FingerMotion, PodcastOne, and MOGU—that are on the radar, weighing their potential against significant financial challenges.
Despite posting record earnings in its theme parks division, The Walt Disney Company saw its shares tumble sharply following its Q1 FY2026 report, as investor concerns over streaming profitability and rising costs overshadowed the success of its Experiences business.
The actively managed Schwab Core Bond ETF (SCCR), launched in early 2025, is gaining attention for its monthly distributions and a current yield of 4.32%. The fund focuses on high-quality U.S. dollar-denominated debt, offering retirees and other investors a potential source of predictable income in a shifting rate environment.
The Trump administration is moving to establish a major national stockpile of critical minerals, with a $10 billion federal loan and private investment, aiming to reduce reliance on foreign supplies for key technologies.
Despite solid revenue growth, Microvast Holdings (NASDAQ: MVST) has seen its share price collapse over the past five years, erasing billions in market value and testing the patience of long-term investors.
While Medicare provides a crucial safety net at 65, significant gaps in coverage for dental, vision, and long-term care can lead to six-figure annual expenses. Proactive planning with HSAs, specialized insurance, and strategic budgeting is essential to protect retirement savings.
A significant tax deduction increase for seniors, set for 2026 under the 'One Big Beautiful Bill Act,' is projected to hasten the depletion of Social Security trust funds by roughly six months, raising urgent questions about the program's long-term solvency.
Amazon's ongoing corporate restructuring has resulted in significant layoffs across its Seattle-area headquarters, with software engineers among the most affected roles, as the tech giant continues to streamline operations and invest in AI.
The FDA has issued a complete response letter for Aquestive Therapeutics' sublingual epinephrine film Anaphylm, citing concerns over packaging and user instructions. The company aims to address the issues and resubmit its application by the third quarter of this year.
Tyson Foods reported mixed Q1 FY2026 results, with strong momentum in Prepared Foods and Chicken segments offset by significant challenges in Beef due to constrained cattle supplies. The company also unveiled a new segment reporting structure aimed at enhancing transparency for investors.
Life sciences and diagnostics firm Revvity (RVTY) closed 2025 with results surpassing internal targets, driven by robust diagnostics performance. While management provided initial 2026 guidance, it remains conservative, banking on market stabilization rather than a broad recovery.
Synthetic biology leader Twist Bioscience reported strong Q1 FY2026 results, with revenue climbing 17% year-over-year to $103.7 million. Management highlighted accelerating demand from AI-powered drug discovery and reiterated its path to adjusted EBITDA breakeven by Q4 FY2026.
As major indices climb, investors are sifting through economic crosscurrents to find resilient tech innovators. We examine three companies—Veracyte, monday.com, and Zeta Global—whose strategic moves and financial momentum position them for potential growth.
Amidst a resilient market backdrop, we spotlight three U.S. stocks trading significantly below their estimated intrinsic value, offering potential for investors willing to navigate current volatility.
Amid a backdrop of cautious market optimism, companies with significant insider ownership are drawing investor attention. We examine three firms where those closest to the business are putting their money, spanning biotech, advanced semiconductors, and regional banking.
A powerful but uncommon shift in market leadership is underway as small-caps, energy, and value stocks drive gains. While a sign of health, historical parallels to similar 'breadth' events often coincided with economic stress.
Amid market volatility driven by AI speculation, a seasoned investor makes the case for a dual-anchor strategy built on Apple's surging iPhone sales and Berkshire Hathaway's formidable $378 billion cash reserve.
NuScale Power's stock has surged over 640% since early 2024, fueled by investor optimism around its small modular reactor technology. While the potential is vast, analysts caution the road ahead remains fraught with financial and regulatory challenges.
